Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Risperdal Breast Growth Lawsuit Goes to Trial in Philadelphia January 26, 2015 Irvin Jackson Add Your Comments Trial is underway in Pennsylvania state court for a Risperdal lawsuit brought against Johnson & Johnson and its Janssen subsidiary, which alleges that the drug maker failed to adequately warn that young boys prescribed the antipsychotic may experience abnormal breast growth. Opening arguments commenced on January 23, in a case filed by 20 year-old Austin Pledger. According to the lawsuit, Pledger indicates that side effects of Risperdal use for autism when he was 8 years old has left him with a medical condition known as gynecomastia, which has caused the growth of large female breasts that may require a double mastectomy. The case is one of more than 1,250 similar Risperdal breast growth lawsuits currently centralized in the Philadelphia Court of Common Pleas, where mass tort proceedings have been established for the claims that allege the drug makers knew about the potential risks, yet withheld information from consumers and the medical community. Learn More About Risperdal Lawsuits Side effects of Risperdal linked to risk of breast growth among young boys, or gynecomastia. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Risperdal Lawsuits Side effects of Risperdal linked to risk of breast growth among young boys, or gynecomastia. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Gynecomastia is a medical disorder associated with the growth of breast tissue among males. In many of the Risperdal cases, plaintiffs allege that the breast development caused by the medication resulted in the need for surgical treatment to remove the breasts, which will leave them with scarring and other physical injury, as well as severe psychological damage from Risperdal breast growth. Johnson & Johnson has been quietly dealing with breast growth litigation over Risperdal for years, but the number of cases has continued to grow as more families and young adults learn that there may be a link between problems suffered following a diagnosis of gynecomastia and Risperdal use as a child. The trial of the Pledger case is the first in what is expected to be a series of Risperdal bellwether trials this year, which are designed to help the parties gauge how juries may respond to certain evidence and testimony that is likely to be offered throughout the litigation. Although the outcomes of these early test trials are not binding on other cases, they may influence negotiations with Johnson & Johnson to reach Risperdal settlements in an attempt to avoid setting hundreds of individual cases for trial in the state. Tags: Gynecomastia, Johnson & Johnson, Male Breast Growth, Pennsylvania, Risperdal More Risperdal Lawsuit Stories Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders December 14, 2022 Breast Cancer Side Effects Linked to Antipsychotic Medications: Study December 9, 2021 $70 Million Verdict in Risperdal Lawsuit Upheld After U.S. Supreme Court Declines To Review May 18, 2021 1 Comments Ricik March 22, 2015 We feel Austin would have gotten more out of this trial, especially if he was able to give the jury a hands on account of how he had to deal with the horrors of living with gynecomastia. Johnson and Johnson are now ramping up their defense. Let’s hope these multi county actions stay strong. Rick Haspery howtostopgynecomastia.com Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders December 14, 2022
$70 Million Verdict in Risperdal Lawsuit Upheld After U.S. Supreme Court Declines To Review May 18, 2021
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)